-
How are the World Cup favourites shaping up?
-
Taiwan leader says 'foreign forces' cannot decide island's future
-
Knicks rally to stun Cavs in overtime in NBA Eastern Conference finals opener
-
Pressure mounts at United Nations for climate change 'lifeline'
-
Cubans want change, but not at gunpoint
-
Asia stocks slide on inflation fears as yields surge
-
Putin, Xi to underscore alliance strength after Trump visit
-
Help wanted: Australian conservation group seeks new koala rescue dog
-
Musk's empire as SpaceX counts down to Wall Street liftoff
-
SpaceX's IPO moonshot draws some doubters on Wall Street
-
Under Trump pressure, EU agrees to implement US trade pact
-
Republican who stood up to Trump defeated in Kentucky primary
-
Acting US attorney general defends fund for prosecuted Trump allies
-
Mavericks part ways with head coach Kidd
-
Shock and bafflement at San Diego mosque where three were killed
-
US enforces law to crack down on sexual deepfakes
-
Arsenal crowned Premier League champions after Man City draw
-
New York art auctions roar back with blockbuster sales
-
US says held talks with Cuba on $100 mln offer
-
Chelsea beat Spurs to leave rivals in 'embarrassing' relegation danger
-
Google wants its search bar to act on your behalf in AI revamp
-
Taiwan author wins International Booker for 'slyly sophisticated' novel
-
Iran 'very confident' about World Cup protocols: federation vice-president
-
Google unveils smart glasses, taking on Meta
-
Guardiola swerves Man City exit talk as title hopes ended
-
Chiefs' Rice jailed for probation violation
-
Five factors in Arsenal's Premier League title triumph
-
Mikel Arteta: Pep protege to Premier League winner
-
How Arsenal banished 'nearly men' tag to end 22-year title wait
-
Arsenal win Premier League after Man City held by Bournemouth
-
From graduation boos to voter unease: AI anxiety grows in the US
-
Lost in Trump's climate boast: best-case scenario abandoned
-
Hantavirus cruise operator says ship not source of outbreak
-
Trump shows off ballroom site with 'drone empire' planned for roof
-
Rubio to attend NATO talks, pay first visit to India
-
Under Trump pressure, EU seeks deal to end trade standoff
-
Airbus seeks to cut peripheral expenses due to Mideast war
-
France encourages women to report rape in probes of star Bruel
-
Guardiola silent on Man City exit reports
-
Argentine researchers collect rodents for hantavirus tests
-
Iran talks making 'good progress': US VP Vance
-
Teen wonder Sooryavanshi's slams 93 to edge Rajasthan closer to IPL play-offs
-
Norway reports Europe's first case of bird flu in a polar bear
-
Italy's Ganna wins time-trial in Giro shake-up
-
EU vows help for farmers hit by Iran war fertiliser price hikes
-
Emery focused on Villa glory, not crown of Europa League 'king'
-
French govt slams 'disproportionate' Canal+ riposte to anti-Bollore petition
-
US, Iran trade threats but Trump says Tehran wants peace deal
-
Russia's Zvyagintsev sets film amid 'disaster' Ukraine war
-
UK trade minister hopes Britain will rejoin EU 'in my lifetime'
Japan firm probing 76 more deaths in supplement scare
Japanese health supplement maker Kobayashi Pharmaceutical said Friday it was probing 76 more deaths possibly linked to its tablets containing red yeast rice, meant to lower cholesterol.
It deepens a scandal that erupted earlier this year when the company said it was looking into five deaths potentially linked to the over-the-counter products after dozens of customers reported kidney problems.
Fermented with a mould culture, red yeast rice, or "beni koji", has been used in food, alcoholic drinks and folk medicines for centuries around East Asia.
"Even if the direct cause of hospitalisation or death was not kidney-related disease, it has become clear that there are a variety of cases, including cases in which beni koji-related products may have caused harm somehow and had some indirect impact," a Kobayashi statement said.
Of the five initial deaths under investigation, the company said it now knows one did not consume red yeast rice.
"We have received 1,656 inquiries from individuals who have sought medical attention, and have 76 cases under investigation over (a causal) connection to the deaths," in addition to the original four, it said.
On March 22, Kobayashi Pharmaceutical said it was recalling three kinds of tablets containing beni koji.
It later said it had detected a potentially toxic acid produced by the mould at one of its factories, and government officials inspected the firm's facilities.
Kobayashi Pharmaceutical is a household name in Japan, offering a wide range of health-related products, and the scandal has been top news in the country.
On Friday, Kobayashi said it would work to identify the exact cause and scope of the health damage -- including whether organs other than kidneys were harmed.
Top government spokesman Yoshimasa Hayashi said Friday that the health ministry had previously ordered the company to file a daily report on its probe, and demanded more details earlier this month after the number of deaths under investigation didn't change.
"But until today, it had not reported the specific number of cases under investigation, and it is extremely regrettable," Hayashi told reporters.
Kobayashi Pharmaceutical has said it also sold red yeast rice to around 50 other firms in Japan and two in Taiwan.
Taiwanese companies preventively recalled 154 products containing red yeast rice in the wake of the scare, the island's health authorities said earlier this year.
F.Qawasmeh--SF-PST